Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore wealth accumulation tips for single parent families to pave the way for financial success. Empower your family's future with smart strategies.
21,770 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As driverless taxis move from test zones to real streets, Alphabet and its Waymo unit sit at the center of the race. ...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
A billionaire’s online rant against a respected paper can ripple through markets and wallets. This article explains w...
As Shake Shack charts a path into 2025, investors seek clarity on margins, store growth, and digital momentum. This g...
Investors watch the moves of billionaires to learn how they navigate risk and opportunity. This piece breaks down how...
Geopolitical headlines push crypto traders toward nonstop venues. This piece explains why hyperliquid's token rises w...
BigBear.ai has emerged as a key name in enterprise AI and decision intelligence. This guide breaks down bigbear.ai (b...
In February, Fluor Corp. shares kept climbing as demand for infrastructure and energy projects stayed resilient. This...
Artemis II tightens the horizon for space infrastructure spending as major primes and component makers post strong ba...
When a promising growth stock pulls back 21% from its recent high, many investors hesitate. This guide shows how to v...
In this artificial intelligence stocks march moment, savvy investors seek clarity on durable bets. This guide breaks ...